Metabolix, Inc. (MBLX)
Q1 2012 Earnings Call
April 26, 2012 4:30 PM ET
Richard Eno – President and CEO
Joseph Hill – CFO
Laurence Alexander – Jefferies
Mike Ritzenthaler – Piper Jaffray
JinMing Liu – Ardour Capital
Jeff Zekauskas – JP Morgan
Jeff Osborne – Stifel Nicolaus
Please stand by. We are about to begin. Good afternoon ladies and gentlemen thank you for standing by. Welcome to the Metabolix Inc. First Quarter and Fiscal Year 2012 Earnings Conference Call. Today’s call is being recorded. At this time, all participants are in a listen-only mode. Following the presentation, we will conduct a question-and-answer session. Instructions will be provided at that time for you to queue up for your questions.
I would like to turn the conference over to (inaudible) of ICR. Please go ahead.
Unidentified Company Representative
Thank you, and good afternoon, everyone. Metabolix released first quarter 2012 financial results after the market closed today. If you do not have a copy, one may be found on the website at www.metabolix.com in the Investor Relations section. In addition, today we have provided several slides to accompany the presentation. These slides will also become available on the Metabolix’s website following today’s call.
Making the presentation today will be Richard Eno, President and Chief Executive Officer of Metabolix; and Joseph Hill, Chief Financial Officer of the company. They are joined by Oliver Peoples, the Co-Founder of Metabolix and Chief Scientific Officer.
Before we begin our formal remarks, I need to remind everyone that part of our discussion today will include forward-looking statements. These statements are not guarantees of future performance, and therefore undue reliance should not be put upon them. Investors are also cautioned that statements in the discussion today, which are not strictly historical statements constitute forward-looking statements.
Check Out Our Best Services for Investors
Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts